A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
The purpose of this study is to learn about the effects of the study treatment, Dendritic Cell Vaccine (DCV), to find the highest dose of the study treatment that can be given safely to Breast Cancer patients with Leptomeningeal Disease
Leptomeningeal Disease|Triple Negative Breast Cancer|HER2-positive Breast Cancer
BIOLOGICAL: Dendritic Cell Vaccine
Maximum Tolerated Dose of Intrathecal Dendritic Cell Vaccine, Maximum tolerated dose of intrathecal dendritic cell vaccine is defined as the highest dose of vaccine that does not cause undesirable side effects/dose limiting toxicity (DLT). To evaluate safety, the study team will monitor toxicities continuously and the study will be halted if an excessive number of toxicities are encountered., Up to 12 weeks
Overall Survival, Overall Survival (OS) will be measured from the initial date of treatment to the recorded date of death., Up to 12 months|Progression Free Survival, Progression Free Survival defined as the time from start of treatment to the time of progression or death., Up to 12 months
The purpose of this study is to learn about the effects of the study treatment, Dendritic Cell Vaccine (DCV), to find the highest dose of the study treatment that can be given safely to Breast Cancer patients with Leptomeningeal Disease